Matrix stiffness-upregulated LOXL2 promotes fibronectin production, MMP9 and CXCL12 expression and BMDCs recruitment to assist pre-metastatic niche formation.
about
Matrix stiffness-upregulated LOXL2 promotes fibronectin production, MMP9 and CXCL12 expression and BMDCs recruitment to assist pre-metastatic niche formation.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh
2018年學術文章
@zh-hant
name
Matrix stiffness-upregulated L ...... re-metastatic niche formation.
@en
Matrix stiffness-upregulated L ...... re-metastatic niche formation.
@nl
type
label
Matrix stiffness-upregulated L ...... re-metastatic niche formation.
@en
Matrix stiffness-upregulated L ...... re-metastatic niche formation.
@nl
prefLabel
Matrix stiffness-upregulated L ...... re-metastatic niche formation.
@en
Matrix stiffness-upregulated L ...... re-metastatic niche formation.
@nl
P2093
P2860
P1476
Matrix stiffness-upregulated L ...... pre-metastatic niche formation
@en
P2093
Dongmei Gao
Jiefeng Cui
Qiongdan Zheng
Rongxin Chen
Tongchun Xue
Xiaoxia Xing
P2860
P2888
P356
10.1186/S13046-018-0761-Z
P50
P577
2018-05-04T00:00:00Z
P6179
1103813581